outbreak
sever
acut
respiratori
syndrom
sar
control
public
health
measur
time
specif
intervent
antivir
drug
vaccin
immunotherapi
avail
sinc
sever
anim
model
develop
studi
sar
although
model
replic
human
diseas
aspect
use
anim
model
sar
led
establish
sever
import
principl
vaccin
immunotherapi
consist
reproduc
find
given
model
must
demonstr
establish
superior
one
model
other
suggest
aspect
ideal
anim
model
studi
sar
pathogenesi
vaccin
develop
present
assess
strength
limit
current
anim
model
sar
emerg
identif
sarscov
new
human
pathogen
earli
outbreak
sever
respiratori
diseas
first
came
attent
public
health
author
hong
kong
rapidli
spread
canada
singapor
vietnam
return
travel
week
case
death
due
sever
acut
respiratori
syndrom
sar
report
countri
http
wwwwhointcsrsarscountri
outbreak
control
public
health
measur
includ
use
broad
case
definit
hospit
isol
suspect
case
quarantin
travel
advisori
etiolog
agent
sar
novel
coronaviru
cov
refer
sarscov
introduc
human
anim
reservoir
virus
close
relat
sarscov
isol
civet
cat
horsesho
bat
sourc
sarscov
definit
identifi
sinc
larg
global
outbreak
limit
number
case
sar
occur
includ
four
communityacquir
infect
associ
mild
diseas
follow
winter
least
four
laboratoryacquir
infect
one
result
secondari
spread
sever
ill
mortal
contact
although
difficult
predict
whether
anoth
outbreak
sar
occur
exposur
infect
anim
laboratoryacquir
infect
immedi
recogn
two
potenti
sourc
infect
high
morbid
mortal
rate
econom
consequ
outbreak
togeth
potenti
infect
futur
reason
continu
global
interest
develop
measur
prevent
control
sar
antivir
drug
immunotherapi
vaccin
sar
evalu
anim
model
ration
select
appropri
model
studi
depend
care
assess
review
avail
model
summar
find
current
anim
model
sar
discuss
learn
model
util
benefit
limit
controversi
surround
model
also
discuss
furthermor
suggest
direct
futur
research
facilit
resolut
controversi
find
present
outstand
research
question
field
intern
cooper
coordin
led
rapid
identif
sarscov
control
sar
outbreak
exemplari
effort
develop
anim
model
undertaken
sever
laboratori
around
world
experiment
infect
differ
anim
model
proven
invalu
establish
basi
prevent
control
strategi
sar
howev
publish
report
laboratori
use
differ
anim
model
led
controversi
opinion
misunderstand
anim
model
sar
essenti
find
given
model
consist
reproduc
featur
well
document
use
differ
anim
model
tailor
goal
studi
consist
reproduc
relev
outcom
measur
scientif
question
immunogen
efficaci
vaccin
pathogenesi
diseas
must
consid
one
conclud
given
model
superior
avail
model
prefer
appropri
model
clearli
pathogenesi
diseas
studi
anim
model
replic
key
aspect
diseas
anim
model
need
replic
aspect
diseas
provid
use
inform
evalu
vaccin
immunoprophylaxi
exampl
anim
model
use
vaccin
efficaci
studi
follow
two
criteria
met
viru
titer
correl
diseas
sever
ii
viru
replic
anim
model
suffici
high
titer
differ
level
replic
immun
mockimmun
control
group
meaning
distinguish
condit
demonstr
vaccin
antibodi
prevent
significantli
reduc
level
replic
challeng
viru
would
convinc
evid
efficaci
ampl
preced
approach
develop
vaccin
respiratori
virus
widespread
unsubstanti
belief
ferret
nonhuman
primat
accept
model
studi
sar
base
experi
studi
sarscov
infect
sever
speci
includ
mice
hamster
three
speci
nonhuman
primat
care
review
publish
report
would
argu
pro
con
anim
model
choic
model
use
guid
natur
studi
tabl
surprisingli
reproduc
data
viru
replic
obtain
inbr
mice
golden
syrian
hamster
inbr
limit
genet
heterogen
mous
speci
infect
sarscov
includ
balbc
svev
stat
knockout
mice
sarscov
administ
intranas
lightli
anesthet
balbc
mice
viru
replic
high
titer
upper
lower
respiratori
tract
nasal
turbin
lung
tissu
respect
without
associ
sign
morbid
mortal
viru
replic
respiratori
tract
peak
day
two
three
postinfect
pi
accompani
substanti
pulmonari
inflamm
pneumon
viru
clear
lung
day
five
seven
pi
transient
weight
loss
pneumon
seen
strain
mice
follow
sarscov
infect
old
balbc
mice
develop
sign
clinic
ill
weight
loss
ruffl
fur
mild
dehydr
histopatholog
evid
diseas
bronchiol
patchi
interstiti
pneumon
diffus
alveolar
damag
follow
sarscov
infect
agerel
increas
morbid
balbc
mice
reminisc
observ
human
sar
outbreak
age
signific
risk
factor
sever
diseas
poor
outcom
sarscov
replic
high
titer
respiratori
tract
mice
find
mice
highli
reproduc
mous
model
use
evalu
vaccin
immunoprophylaxi
antivir
drug
addit
avail
rang
immunolog
reagent
knockout
mice
make
possibl
carri
studi
pathogenesi
mice
develop
pneumon
associ
viral
replic
golden
syrian
hamster
excel
model
sarscov
infect
viru
replic
high
titer
respiratori
tract
tissu
cultur
infecti
dose
tcid
per
gram
lung
tissu
follow
intranas
administr
tcid
viru
associ
interstiti
pneumon
pulmonari
consolid
diffus
alveolar
damag
infect
accompani
overt
clinic
ill
viru
clear
seven
ten
day
pi
mice
sarscov
infect
golden
syrian
hamster
elicit
robust
neutral
antibodi
respons
previous
infect
hamster
protect
subsequ
infect
correl
level
viru
recov
lung
extent
pneumon
demonstr
sarscov
infect
hamster
fact
sarscov
reproduc
replic
extrem
high
titer
respiratori
tract
hamster
associ
pneumon
make
excel
model
evalu
vaccin
immunoprophylaxi
immunotherapi
sar
ferret
domest
cat
found
suscept
infect
sarscov
studi
domest
cat
report
viru
replic
lung
follow
intranas
infect
report
associ
pneumon
conflict
unpublish
report
presenc
natur
sever
clinic
find
ferret
photomicrograph
evolut
histopatholog
find
follow
primari
infect
sarscov
ferret
publish
yet
possibl
compar
find
ferret
anim
model
therefor
base
evalu
publish
report
would
prematur
conclud
ferret
superior
model
sar
nonhuman
primat
model
sever
speci
old
new
world
primat
evalu
model
sar
viru
administ
respiratori
tract
infect
cynomolgu
rhesu
macaqu
african
green
monkey
common
marmoset
report
variabl
degre
associ
clinic
ill
diseas
alongsid
variabl
success
isol
infecti
viru
tissu
attempt
experiment
infect
squirrel
monkey
mustach
tamarin
success
k
subbarao
robert
unpublish
viru
replic
detect
respiratori
tract
cynomolgu
rhesu
macaqu
african
green
monkey
least
one
report
pneumon
speci
fever
wateri
diarrhea
pneumon
hepat
observ
common
marmoset
one
group
investig
studi
sarscov
infect
african
green
monkey
common
marmoset
wherea
two
group
investig
evalu
cynomolgu
rhesu
macaqu
unfortun
report
clinic
ill
cynomolgu
rhesu
macaqu
variou
group
contradictori
clearli
sever
factor
contribut
differ
find
differ
investig
includ
age
sourc
anim
environment
histori
possibl
presenc
copathogen
dose
rout
inocul
strain
viru
administ
howev
find
reproduc
outbr
speci
demonstr
biolog
variabl
becom
particularli
import
studi
carri
larg
sampl
size
draw
meaning
conclus
difficulti
conduct
studi
nonhuman
primat
larg
sampl
size
limit
util
ideal
anim
model
learn
much
correl
immun
use
current
anim
model
sar
research
experi
mice
target
defect
immun
system
suggest
innat
immun
import
role
clearanc
sarscov
addit
studi
shown
intranas
administ
sarscov
replic
respiratori
tract
sever
anim
speci
protect
anim
reinfect
sarscov
addit
primari
infect
activ
immun
inactiv
whole
viru
vaccin
dna
vaccin
subunit
vaccin
live
vector
vaccin
express
sarscov
spike
protein
also
elicit
neutral
antibodi
sarscov
provid
protect
subsequ
challeng
tabl
furthermor
passiv
transfer
postinfect
postimmun
sera
monoclon
antibodi
spike
protein
also
protect
mice
ferret
hamster
infect
modul
diseas
tabl
moreov
deplet
tcell
mice
immun
dna
vaccin
encod
spike
protein
gene
abrog
protect
sarscov
challeng
adopt
transfer
tcell
immun
mice
mice
confer
protect
sarscov
challeng
find
strongli
suggest
vaccin
elicit
humor
immun
sarscov
spike
protein
immunotherapi
target
spike
protein
suffici
protect
sar
infect
associ
diseas
research
anim
model
led
identif
correl
immun
protect
abil
activ
induc
neutral
antibodi
passiv
transfer
neutral
antibodi
principl
provid
basi
prevent
intervent
strategi
event
sarscov
reappear
human
conclus
develop
anim
model
sar
progress
rapidli
describ
model
rang
viru
replic
observ
young
balbc
mice
model
viru
replic
accompani
histopatholog
evid
diseas
hamster
ferret
african
green
monkey
cynomolgu
rhesu
macaqu
consist
find
clinic
ill
histopatholog
evid
diseas
observ
old
balbc
mice
although
much
learn
sinc
initi
descript
variou
anim
model
subsequ
studi
vaccin
therapeut
prophylaxi
strategi
studi
differ
anim
model
limit
variou
model
box
must
also
recogn
avail
data
yet
support
conclus
singl
prefer
model
sar
intervent
prevent
strategi
must
evalu
research
undertaken
exist
new
anim
model
address
outstand
question
list
well
prior
infect
vaccin
protect
anim
infect
genet
distinct
sarscov
anim
strain
sarscovlik
virus
ii
long
protect
induc
vaccin
last
iii
vivo
correl
enhanc
entri
mediat
antibodi
certain
sarscovlik
antibodi
